Lack of essential and affordable medicines in India revealed

January 25, 2018, Newcastle University

Research has revealed the shocking lack of access to essential medicines in India, despite thousands being approved in an attempt to generate wider availability.

Researchers at Newcastle University, UK and in Mumbai, India publishing in the Journal of Global Health, found that policy to open up the market has generated a large number of brands of medicines, but there are still not enough available in the pharmacies.

This study assessed the rational use - those drugs shown to be safe and effective with good evidence - and availability of six essential medicines in 124 private pharmacies in Maharashtra State, India.

In theory, competition within India's vast market for should ensure that essential medicines are available in private retail outlets at a price people can afford. However, the study found that despite there being multiple approved products listed in India databases, few were available in private pharmacies at a price people could afford.

Lead author, Dr Colin Millard from Newcastle University's Institute of Health and Society said: "What is worrying is that despite efforts to increase availability through market competition there remains inadequate access to essential medicines.

"We found that multiple brands of selected medicines are listed in professional and commercial databases -running into thousands - yet only a small fraction were available in private pharmacies."

Thousands of medicines approved, yet few available

The researchers examined the drugs available for six common needs: artemisinin (malaria), lamivudine (HIV/AIDS), rifampicin (TB control), oxytocin (reproductive health), fluoxetine (mental health) and metformin (diabetes). The study found that for each of the medicines there were multiple approved products listed in Indian databases, 2186 in total.

They found that only metformin was easily available- in 91% of the pharmacies studied- followed by rifampicin which was present in just above half the pharmacies (64.5%). The other four medicines were available in less than half.

In addition, the medicines were also available in fixed dose combinations (FDCs), where two or more drugs are combined in a set ratio in a single dose form, usually a tablet or capsule. There are concerns in India over the safety and effectiveness of these products. In 2007, the Indian regulatory body the Central Drugs Standard Control Organization (CDSCO) banned 294 FDCs which had been approved by state authorities but had never received central authorisation; in 2012 a further 45 FDCs were withdrawn.

Dr Millard adds: "The high level of approved products available on the Indian market also raises questions about rational use, that is are they being used in unsafe combinations?"

The authors call for a review of available brands, taking into consideration levels of sale and grounds for approval, and the setting up of a centralised database of registered pharmaceutical products.

Explore further: Tackling the rising sale of unapproved antibiotics in India

More information: Colin Millard et al, Availability of brands of six essential medicines in 124 pharmacies in Maharashtra, Journal of Global Health (2018). DOI: 10.7189/jogh.08.010402

Related Stories

Tackling the rising sale of unapproved antibiotics in India

October 10, 2017
Indian government needs to do more to tackle rising sale of unapproved antibiotics, according to an analysis by researchers at Newcastle University and Queen Mary University of London.

Many fixed-dose drug combinations in India lack central regulatory approval

May 12, 2015
Fixed-dose drug combinations (FDCs) which have not received central regulatory approval are sold in substantial numbers in India—despite concerns over the safety and efficacy of these combinations—according to new research ...

Canada needs essential medicines list to ensure supply

June 13, 2016
Canada needs to create a list of essential medicines to help protect against drug shortages, argues an analysis in CMAJ (Canadian Medical Association Journal)

Large market share for non-quality-assured malaria medicines in Africa

May 25, 2017
A new study of malaria medicine quality in 8 sub-Saharan African countries has found a large and potentially growing market for non-quality-assured (QA) malaria treatments—medicines not pre-approved by global health organisations ...

Asthma medicines a struggle for many countries

October 16, 2013
(Medical Xpress)—The availability, pricing and affordability of three essential asthma medicines varies greatly according to a new study of 52 low-and middle-income countries

Some WHO-approved malaria drugs fall short: study

July 10, 2012
Up to eight percent of malaria drugs approved by the World Health Organization or other regulators do not contain the right dose and may fuel resistance, researchers said Tuesday.

Recommended for you

What makes us well? Diversity, health care, and public transit matter

May 23, 2018
Diverse neighbors. Health centers. Commuter trains. These community attributes, and other key factors, are linked to well-being and quality of life, according to Yale researchers.

Study: Strenuous exercise in adolescence may ward off height loss later in life

May 23, 2018
A new study has identified several key factors in postmenopausal women that are associated with height loss, a common occurrence in this age group that is known to increase the risk for death and disease.

Early physical therapy benefits low-back pain patients

May 22, 2018
Patients with low-back pain are better off seeing a physical therapist first, according to a study of 150,000 insurance claims.

Closing coal, oil power plants leads to healthier babies

May 22, 2018
Shuttering coal- and oil-fired power plants lowers the rate of preterm births in neighboring communities and improves fertility, according to two new University of California, Berkeley, studies.

Researchers publish study on new therapy to treat opioid use disorder

May 22, 2018
Better delivery of medications to treat opioid use disorder (OUD) is key to addressing the opioid crisis and helping the 2.6 million Americans affected by the disease.

Insufficient sleep, even without extended wakefulness, leads to performance impairments

May 21, 2018
Millions of individuals obtain insufficient sleep on a daily basis, which can lead to impaired performance and other adverse physiological outcomes. To what extent these impairments are caused by the short sleep duration ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.